EMEA And APAC Expansion Combined With Rising Retail Demand Will Shape Future Trading

Key Takeaways

• Strong global demand for risk management, retail engagement, and international expansion drives volume and revenue growth, diversifying CME's client base.
  
• Innovation in products, technology, and partnerships enhances efficiency and margins, positioning CME for sustainable long-term earnings growth.
  
• Competitive threats from DeFi, regulatory shifts, and low volatility could erode CME Group's market share, trading volumes, and profit margins over time.

Catalysts

Operates contract markets for the trading of futures and options on futures contracts worldwide.

• Heightened global macroeconomic uncertainty, record sovereign debt issuance, persistent geopolitical tensions, and ongoing trade disputes are fueling sustained demand for risk management and hedging solutions, evidenced by record contract volumes and open interest; this trend is likely to support continued revenue and fee growth.
  
• Robust international expansion-with record-breaking double-digit ADV growth across EMEA and APAC and rising participation from both institutional and retail clients globally-broadens CME's addressable market and underpins future volume and revenue growth.
  
• The rapid acceleration of retail engagement, highlighted by a 56% increase in new retail traders and five consecutive quarters of double-digit retail client acquisition growth, diversifies CME's client base and supports both volume and transaction-based revenue growth.
  
• New product innovations (e.g., Micro contracts, expansion into crypto, FX Spot+), ongoing tech-driven operating efficiencies (cloud migration and tokenization initiatives), and strengthening of strategic partnerships (such as the long-term NASDAQ index license extension and Google Cloud collaboration) are enhancing operating leverage and EBITDA/net margin performance.
  
• The ongoing global shift toward electronic trading, greater regulatory demands for transparency and standardized clearing, and a proven ability to grow non-transactional revenue (e.g., record market data revenue) position CME to capture a larger share of trading activity and support durable long-term earnings growth.

CME Group Future Earnings and Revenue Growth

Assumptions

• Analysts are assuming CME Group's revenue will grow by 4.8% annually over the next 3 years.
• Analysts assume that profit margins will increase from 57.1% today to 57.5% in 3 years time.
• Analysts expect earnings to reach $4.1 billion (and earnings per share of $11.78) by about July 2028, up from $3.6 billion today. However, there is some disagreement amongst the analysts with the more bearish ones expecting earnings as low as $3.7 billion.
• In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 30.5x on those 2028 earnings, up from 27.6x today. This future PE is greater than the current PE for the US Capital Markets industry at 29.1x.
• Analysts expect the number of shares outstanding to grow by 0.07% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 7.68%, as per the Simply Wall St company report.

CME Group Future Earnings Per Share Growth

Risks

• Prolonged periods of geopolitical stability and reduced headline risk could curb market volatility, lowering overall demand for risk-hedging and derivatives trading, which may lead to declining trading volumes and negatively impact CME Group's revenue and earnings growth.
  
• The accelerating adoption of decentralized finance (DeFi) and tokenization technologies poses a long-term competitive threat, as new market structures could enable trading and settlement of derivatives outside of centralized venues like CME, potentially reducing future market share and fee revenues.
  
• CME's continued heavy reliance on trading activity in interest rate and equity futures exposes the company to periods of subdued volatility or volume in those sectors, which could result in revenue stagnation or contraction and put pressure on net margins.
  
• Regulatory changes-such as potential increased oversight of retail derivatives trading, limitations on certain products (e.g., perpetuals in the U.S.), or global moves to further tighten derivatives market participation-may dampen speculative activity and reduce overall transaction fees and open interest.
  
• Intensifying industry competition from alternative electronic trading venues, lower-fee platforms, and the proliferation of OTC derivatives and algorithmic solutions could create sustained pricing pressure, eroding net margins and constraining CME's long-term earnings growth.

Valuation

• The analysts have a consensus price target of $280.556 for CME Group based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $313.0, and the most bearish reporting a price target of just $213.0.
  
• In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $7.2 billion, earnings will come to $4.1 billion, and it would be trading on a PE ratio of 30.5x, assuming you use a discount rate of 7.7%.
  
• Given the current share price of $274.64, the analyst price target of $280.56 is 2.1% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.